NCT05155371

Brief Summary

Optimal intraoperative positive end expiratory pressure (PEEP) improves the outcome. Optimal PEEP is not only very different among individuals, but each individual's optimal PEEP is affected by positioning, muscle paralysis, and several other factors. Several techniques have been used to determine the optimal PEEP. For example, electrical impedance tomography(EIT)can be performed at the bedside.However, the application of this technique requires special training, increases the workload of the care team, and the cost-efficiencyof this procedure remains to be determined.We hypothesized that optimal PEEP could be obtained by titration of intraoperative PEEP levels and FiO2with SpO2 guidance. Our secondary hypothesis was that maintenance of intraoperative optimal PEEP derived via this method improves intraoperative oxygenation and reduces the incidence of postoperative hypoxemia.We tested our hypothesis in patients undergoing robotic-assisted laparoscopic prostatectomy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 20, 2021

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

November 18, 2021

Completed
25 days until next milestone

First Posted

Study publicly available on registry

December 13, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 8, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2023

Completed
Last Updated

February 15, 2023

Status Verified

February 1, 2023

Enrollment Period

1.1 years

First QC Date

November 18, 2021

Last Update Submit

February 13, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • The difference of optimal PEEP titrated by two methods

    Titration result of the two groups

    within 30 minutes after trachea intubation

Secondary Outcomes (4)

  • Difference of intraoperative PaO2/FiO2 between the two groups

    30,60,120 minutes after finishing PEEP titration

  • Difference of intraoperative driving pressure, dynamic compliance between the two groups

    30,60,120 minutes after finishing PEEP titration

  • Difference of lung regional ventilation between the two groups

    5 minutes after trachea extubation

  • Post operation hypoxemia in PACU.

    within 30 minutes after trachea extubation

Study Arms (2)

Optimal Positive End-expiratory Pressure obtained with Titration of Fraction of Inspiratory Oxygen

EXPERIMENTAL

Obtained Optimal Positive End-expiratory Pressure obtained with Titration of Fraction of Inspiratory Oxygen and sustained the PEEP intraoperatively

Other: Titration of Optimal Positive End-expiratory Pressure

Optimal Positive End-expiratory Pressure obtained with electrical impedance tomography

EXPERIMENTAL

Obtained Optimal Positive End-expiratory Pressure obtained with EIT and sustained the PEEP intraoperatively

Other: Titration of Optimal Positive End-expiratory Pressure

Interventions

Titration of Optimal Positive End-expiratory Pressure with two different methods

Optimal Positive End-expiratory Pressure obtained with Titration of Fraction of Inspiratory OxygenOptimal Positive End-expiratory Pressure obtained with electrical impedance tomography

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult patients aged 18 years or older
  • scheduled for elective robotic-assisted laparoscopic prostatectomy(RALP)
  • ASA physical status of I-III

You may not qualify if:

  • acute or chronic respiratory disorders
  • pulmonary hypertension
  • neuromuscular disease
  • preoperative SpO2\<95% on room air

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

270 Dongan Road, Fudan University Shanghai Cancer Center

Shanghai, 200032, China

Location

Fudan University Shanghai Cancer Center

Shanghai, China

Location

Study Officials

  • Jun Zhang, PhD

    Department of Anesthesiology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department of Anesthesiology, Fudan University Shanghai Cancer Center

Study Record Dates

First Submitted

November 18, 2021

First Posted

December 13, 2021

Study Start

October 20, 2021

Primary Completion

December 8, 2022

Study Completion

January 20, 2023

Last Updated

February 15, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations